Indication
Ventricular rate control in atrial fibrillation
Ventricular rate control in atrial fibrillation is a therapeutic clinical objective targeting the cardiovascular system to manage excessive and irregular ventricular activation caused by rapid, disorganized atrial depolarization. Read more about Ventricular rate control in atrial fibrillation
175 drugs 100 manufacturers
Drugs that treat it
Common Ventricular rate control in atrial fibrillation therapies.
RAPIBLYK (landiolol HCl)
VERAPAMIL HCL
PROPRANOLOL HCL
VERAPAMIL HCL
DILTIAZEM-D5W (diltiazem HCl/dextrose 5 % in water)
DIGOXIN
VERAPAMIL HCL
PROPRANOLOL HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVentricular rate control in atrial fibrillation is a therapeutic clinical objective targeting the cardiovascular system to manage excessive and irregular ventricular activation caused by rapid, disorganized atrial depolarization.
In patients with atrial fibrillation, non-coordinated atrial impulses rapidly conduct across the atrioventricular node, often causing a rapid ventricular response that shortens diastolic filling time, reduces stroke volume, and impairs overall cardiac output.
This clinical state can lead to palpitations, dyspnea, exercise intolerance, angina, or heart failure, and when sustained, poses a significant risk for tachycardia-induced cardiomyopathy.
Modulating nodal conduction to achieve ventricular rate control preserves myocardial function and alleviates symptoms without necessitating the immediate or permanent conversion to normal sinus rhythm.
- nih.gov
Ventricular rate control in atrial fibrillation is a therapeutic clinical objective targeting the cardiovascular system to manage excessive and irregular ventricular activation caused by rapid, disorganized atrial depolarization In patients with atrial fibrillation, non-coordinated atrial impulses rapidly conduct across the atrioventricular node, often causing a rapid ventricular response that shortens diastolic filling time, reduces stroke volume, and impairs overall cardiac output
- nih.gov
Ventricular rate control in atrial fibrillation is a therapeutic clinical objective targeting the cardiovascular system to manage excessive and irregular ventricular activation caused by rapid, disorganized atrial depolarization This clinical state can lead to palpitations, dyspnea, exercise intolerance, angina, or heart failure, and when sustained, poses a significant risk for tachycardia-induced cardiomyopathy Modulating nodal conduction to achieve ventricular rate control preserves myocardial...
- nih.gov
In patients with atrial fibrillation, non-coordinated atrial impulses rapidly conduct across the atrioventricular node, often causing a rapid ventricular response that shortens diastolic filling time, reduces stroke volume, and impairs overall cardiac output
- nih.gov
This clinical state can lead to palpitations, dyspnea, exercise intolerance, angina, or heart failure, and when sustained, poses a significant risk for tachycardia-induced cardiomyopathy
- nih.gov
This clinical state can lead to palpitations, dyspnea, exercise intolerance, angina, or heart failure, and when sustained, poses a significant risk for tachycardia-induced cardiomyopathy Modulating nodal conduction to achieve ventricular rate control preserves myocardial function and alleviates symptoms without necessitating the immediate or permanent conversion to normal sinus rhythm
Personalize your experience
Follow Ventricular rate control in atrial fibrillation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.